Stockreport

Unicycive Therapeutics Successfully Completes UNI-494 Phase 1 Study in Healthy Volunteers [Yahoo! Finance]

Unicycive Therapeutics, Inc.  (UNCY) 
PDF “We are pleased to announce the successful completion of the UNI-494 Phase 1 study that informs our next steps for advancement to a potential Phase 2 clinical trial in [Read more]